Zobrazeno 1 - 10
of 490
pro vyhledávání: '"Schouten, J.A."'
Autor:
Binda, F. *, Tebano, G., Kallen, M.C., ten Oever, J., Hulscher, M.E., Schouten, J.A., Pulcini, C.
Publikováno v:
In Médecine et Maladies Infectieuses August 2020 50(5):414-422
Autor:
Wolbrink, D.R.J., Kolwijck, E., Ten Oever, J., Horvath, K.D., Bouwense, S.A.W., Schouten, J.A.
Publikováno v:
In Clinical Microbiology and Infection January 2020 26(1):18-25
Autor:
Stemkens, R., Schouten, J.A., Kessel, S.A.M. van, Akkermans, R.P., Telgt, D.S.C., Fleuren, Hanneke W.H.A., Claassen, M.A., Hulscher, M.E.J.L., Oever, J. ten
Publikováno v:
Clinical Microbiology and Infection, 29, 182-187
Clinical Microbiology and Infection, 29, 2, pp. 182-187
Clinical Microbiology and Infection, 29, 2, pp. 182-187
Contains fulltext : 290690.pdf (Publisher’s version ) (Open Access) BACKGROUND: Antimicrobial stewardship (AMS) teams are responsible for performing an AMS programme in their hospitals that aims to improve the quality of antibiotic use. Measuring t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kanj, S.S., Haddad, S.F., Meis, J.F., Verweij, P.E., Voss, A., Rautemaa-Richardson, R., Levy-Hara, G., Chowdhary, A., Ghafur, A., Bruggemann, R.J.M., Bal, A.M., Schouten, J.A.
Publikováno v:
International Journal of Antimicrobial Agents, 62, 1
Contains fulltext : 294283.pdf (Publisher’s version ) (Open Access) The COVID-19 pandemic has highlighted the detrimental effect of secondary pathogens in patients with a primary viral insult. In addition to superinfections with bacterial pathogens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1236::7a45a48920bf134fb11a1fc18021685b
Autor:
Ubels, S., Verstegen, M.H.P., Klarenbeek, B.R., Bouwense, S., Berge Henegouwen, M.I. van, Daams, F., Det, M.J. van, Griffiths, E.A., Haveman, J.W., Heisterkamp, J., Nieuwenhuijzen, G., Polat, F., Schouten, J.A., Siersema, P.D., Singh, P., Wijnhoven, B., Hannink, G.J., Workum, F.T.W.E. van, Rosman, C.
Publikováno v:
British Journal of Surgery, 110, 7, pp. 852-863
Contains fulltext : 294540.pdf (Publisher’s version ) (Open Access) BACKGROUND: Anastomotic leak is a severe complication after oesophagectomy. Anastomotic leak has diverse clinical manifestations and the optimal treatment strategy is unknown. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1236::6c1c5392690efddfff032f10fd2c0223
https://repository.ubn.ru.nl/handle/2066/294540
https://repository.ubn.ru.nl/handle/2066/294540
Autor:
Grootveld, Rebecca van, Beek, M.T. van der, Janssen, N.A.F., Ergün, M., Dijk, Karin van, Bethlehem, Carina, Reijers, M.H.E., Bruggemann, R.J.M., Veerdonk, F.L. van de, Verweij, P.E., Schouten, J.A.
Publikováno v:
Journal of Critical Care, 76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::338262050baf2e83c4a56b217f5a2df9
http://hdl.handle.net/2066/293005
http://hdl.handle.net/2066/293005
Autor:
Sieswerda, E., Bax, H.I., Hoogerwerf, J.J., Boer, M.G.J. de, Boermeester, M., Bonten, M.J.M., Dekker, D., Wijk, R.G. van, Juffermans, N.P., Kuindersma, M., Linden, P.D. van der, Melles, D.C., Pickkers, P., Schouten, J.A., Rebel, J.R., Zanten, A.R.H. van, Prins, J.M., Wiersinga, W.J.
Publikováno v:
Sieswerda, E, Bax, H I, Hoogerwerf, J J, de Boer, M G J, Boermeester, M, Bonten, M J M, Dekker, D, van Wijk, R G, Juffermans, N P, Kuindersma, M, van der Linden, P D, Melles, D C, Pickkers, P, Schouten, J A, Rebel, J R, van Zanten, A R H, Prins, J M & Wiersinga, W J 2022, ' The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults ', BMC Infectious Diseases, vol. 22, no. 1, 687 . https://doi.org/10.1186/s12879-022-07653-3
BMC Infectious Diseases, 22(1):687. BioMed Central
BMC Infectious Diseases, 22(1). BMC
BMC infectious diseases, 22(1):687. BioMed Central
BMC Infectious Diseases, 22(1):687. BioMed Central Ltd.
BMC Infectious Diseases, 22
BMC Infectious Diseases, 22, 1
BMC Infectious Diseases, 22(1):687. BioMed Central
BMC Infectious Diseases, 22(1). BMC
BMC infectious diseases, 22(1):687. BioMed Central
BMC Infectious Diseases, 22(1):687. BioMed Central Ltd.
BMC Infectious Diseases, 22
BMC Infectious Diseases, 22, 1
Background The Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on empiric antibacterial therapy of sepsis in adults. Methods Our multidisciplinary guid
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guo, T., Abdulla, A., Koch, B.C.P., Hassel, J.G.C. van, Endeman, H., Schouten, J.A., Elbers, P.W.G., Brüggeman, R.J.M., Hest, R.M.
Publikováno v:
Clinical Pharmacokinetics, 61(6), 869-879. Adis
Clinical Pharmacokinetics, 61(6), 869-879. Adis International Ltd
Clinical Pharmacokinetics, 61, 6, pp. 869-879
Clinical Pharmacokinetics, 61, 869-879
Clinical Pharmacokinetics, 61(6), 869-879
the Dutch Antibiotic PK/PD Collaborators 2022, ' Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients ', Clinical Pharmacokinetics, vol. 61, no. 6, pp. 869-879 . https://doi.org/10.1007/s40262-022-01114-5
Clinical pharmacokinetics, 61(6), 869-879. Adis International Ltd
Clinical Pharmacokinetics, 61(6), 869-879. Adis International Ltd
Clinical Pharmacokinetics, 61, 6, pp. 869-879
Clinical Pharmacokinetics, 61, 869-879
Clinical Pharmacokinetics, 61(6), 869-879
the Dutch Antibiotic PK/PD Collaborators 2022, ' Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients ', Clinical Pharmacokinetics, vol. 61, no. 6, pp. 869-879 . https://doi.org/10.1007/s40262-022-01114-5
Clinical pharmacokinetics, 61(6), 869-879. Adis International Ltd
Contains fulltext : 252099.pdf (Publisher’s version ) (Open Access) BACKGROUND AND OBJECTIVE: Previous pharmacokinetic (PK) studies of ciprofloxacin in intensive care (ICU) patients have shown large differences in estimated PK parameters, suggestin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f26591f4b5eb641fda9de4c334508a
https://pure.eur.nl/en/publications/f62187c2-2389-48f8-9cc8-45f7f0994d8b
https://pure.eur.nl/en/publications/f62187c2-2389-48f8-9cc8-45f7f0994d8b